Supported by an educational grant from Axsome Therapeutics, Inc.

Posters

Characterization of Care Patterns for Patients Newly Diagnosed With Major Depressive Disorder (MDD) in Primary Care Settings: a Retrospective Observational Cohort Study

This retrospective cohort study used an insurer’s claims database.

All Posters

Association between Anhedonia Severity and Clinical and Humanistic Outcomes Among US Adults with Major Depressive Disorder

The relationship between anhedonia severity and the clinical and humanistic burden among patients with MDD is poorly understood. 

Effectiveness of Vortioxetine in Elderly Patients With Major Depressive Disorder in Real-World Clinical Practice: Results From the RELIEVE Study

RELIEVE was a 24-week, observational, prospective, international cohort study in outpatients with MDD initiating vortioxetine treatment at their physician’s discretion in routine care settings (NCT

Clinical burden and treatment satisfaction in patients diagnosed with major depressive disorder (MDD) with prominent anhedonia

Anhedonia is a key symptom of Major Depressive Disorder (MDD), however, there is limited knowledge about the impact of prominent anhedonia on clinical improvement and treatment satisfaction in pati

Antidepressant Changes and App Usage Improve MDD Outcomes in Study to Implement the Pathway Platform in Primary Care: A Post Hoc Subgroup Analysis

The Pathway Platform was designed to enhance patient-provider engagement and encourage use of outcome measures for major depressive disorder (MDD) to improve adherence to measurement-based care (MB

Disease burden associated with prominent anhedonia in patients with major depressive disorder (MDD) from Adelphi Depression Disease Specific Program

Anhedonia is a core symptom of major depressive disorder (MDD).

MDD Treatment Selection: Online CME Illustrates Best Practices in Discussing Pharmacogenomic Testing with Patients

This study examined whether an online CME clinical demonstration module can improve learners’ self-reported clinical behaviors related to management of MDD, identifying patients who may benefit fro

Effects of AXS-05 (Auvelity®) in Improving Anhedonia and Interest-Activity Symptoms of MDD and the Associated Improvements in Functional Impairment

Traditional antidepressant monotherapies are associated with poor outcomes in patients with impaired symptom domains of anhedonia and interest-activity.